About Aktis Oncology
Aktis Oncology is a private company based in Boston, Massachusetts, incorporated in 2020 in Delaware. It has reported $175,000,000 raised in one offering on Form D since October 2024. Its chief executive is Matthew Roden.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 20, 2024 | Oct 2, 2024 | $175,000,000fully sold | 39 | $4.4M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aktis Oncology's Form D filed Oct 2, 2024.
HK
SB
Shulamit Ron-Bigger
Executive officer
KH
Ken Herrmann
Director
LS
Lloyd Segal
Director
ON
Oleg Nodelman
Director
AL
Andrew Levin
Director
MR
TF